Literature DB >> 15369401

Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones.

Mohamed Hadjeri1, Eva-Laure Peiller, Chantal Beney, Nabajyoti Deka, Martin A Lawson, Charles Dumontet, Ahcène Boumendjel.   

Abstract

We report the synthesis of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones and their biological activity as antitumor agents. These molecules were initially evaluated for their ability to induce cell cycle arrest in the G2/M phase. Compounds that showed significant G2/M cell cycle arrest were tested for antiproliferative activity using both the MTT assay and the NCI in vitro 60 cell line human tumor screen. The 5-hydroxy-7-methoxy-2-phenyl-4-quinolone (3a) and 2-(3-fluorophenyl)-5-hydroxy-7-methoxy-4-quinolone (3f) were the most active in the cell cycle arrest test whereas 3f was found to be the most active in the MTT assay. In terms of structural requirements, we found that the presence of a 5-hydroxyl group, a 7-methoxy group, and an unsubstituted N1 were essential for the antimitotic activity. In accordance with the literature, a fluoro group at the 3'- or 2'-position and a methoxy or a chloro group at the 3'-position were found to be highly advantageous for both the cell cycle arrest and the antiproliferative activities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369401     DOI: 10.1021/jm049876x

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Study of the cytotoxic/toxic potential of the novel anticancer selenodiazoloquinolone on fibroblast cells and 3D skin model.

Authors:  Soňa Jantová; Dominika Topoľská; Michaela Janošková; Miroslav Pánik; Viktor Milata
Journal:  Interdiscip Toxicol       Date:  2017-05-17

2.  One-pot synthesis of 2,3,4-triarylquinolines via suzuki-miyaura cross-coupling of 2-aryl-4-chloro-3-iodoquinolines with arylboronic acids.

Authors:  Malose Jack Mphahlele; Mamasegare Mabel Mphahlele
Journal:  Molecules       Date:  2010-10-22       Impact factor: 4.411

3.  Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance.

Authors:  Mårten Fryknäs; Joachim Gullbo; Xin Wang; Linda Rickardson; Malin Jarvius; Malin Wickström; Saadia Hassan; Claes Andersson; Mats Gustafsson; Gunnar Westman; Peter Nygren; Stig Linder; Rolf Larsson
Journal:  BMC Cancer       Date:  2013-08-06       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.